Latest News
Xhale Smart®
Xhale Smart® – Latest News
Xhale submits Biomarker Qualification package to FDA for Medication Adherence Monitoring Tool
Xhale submits Biomarker Qualification package to FDA for Medication…
Xhale's SMART® Adherence Technology Enabled Through Collaboration with Catalent
Xhale announces availability of first solution to enable integration…
Xhale's SMART Technology Showcased at Drug Development, Medication Adherence, and Innovation Meetings
SMART® solution which enables the management of medication adherence…
Xhale Awarded NIH/NIMH SBIR Grant for Monitoring Microbicide Gel Use
GAINESVILLE, FL April 16, 2014 - Xhale SMART, Inc.
Xhale,…
Xhale SMART Achieves Significant Milestone with ISO 13485 Certification
GAINESVILLE, FL December 2, 2013 – Xhale, Inc.
Xhale SMART,…
Xhale’s SMART Biotechnologies Poised to Provide Solutions for Costly Drug Development
GAINESVILLE, FL – February 21, 2013 – Xhale, Inc.
The…
Chief Science Officer of Xhale subsidiary SMART Biotechnologies, Inc. elected an NAI Charter Fellow
The Chief Science Officer of the Xhale, Inc. subsidiary SMART…
SMART Biotechnologies, Inc. Announces the Appointment of Thomas J. Bigger as New Company President
GAINESVILLE, FL – January 8, 2013
SMART Biotechnologies,…
Xhale Awarded National Institute of Drug Abuse (NIDA) Grant for Further Development of Innovative Breath-Based SMART® Adherence Tool.
GAINESVILLE, FL – August 22, 2012
Xhale, Inc. announced…
Xhale Completes NIH-Funded Study on SMART™ Adherence Monitoring System
Xhale, Inc. announced today the successful completion of an NIH-funded…
Xhale Completes Spin Off of SMART Biotechnologies
GAINESVILLE, FL – Oct. 1, 2012 – Xhale, Inc.
Xhale, Inc.…
